Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer
- 12 November 2002
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 23 (4), 349-363
- https://doi.org/10.1002/gepi.10188
Abstract
Breast cancer and prostate cancer are the most commonly occurring cancers in females and males, respectively. The objective of this project was to test the hypothesis that breast cancer in females and prostate cancer in males represent homologous cancers that may be controlled by one or more common unidentified genes that may explain some of the observed familial aggregation. We modeled the transmission of a breast‐prostate cancer phenotype in 389 pedigrees ascertained through a breast cancer proband drawn from the Icelandic Cancer Registry. Assuming that age at diagnosis of this combined phenotype followed a logistic distribution, segregation analyses were performed to evaluate residual parental effects, a sibship covariate, and a dichotomous cohort effect. The most parsimonious model was a Mendelian codominant model, which could partly explain the familial aggregation of both cancers. Inheritance of a putative high‐risk allele (A) predicted gender‐specific mean ages of onset for females as 53.8 years, 59.7 years, and 65.6 years for the putative AA, AB, and BB genotypes, respectively. Similarly, the predicted means were 73.7 years, 75.6 years, and 78.3 years, respectively, among males. Under this codominant model, the lifetime risk of a woman being affected was 19% by age 80 years. This implies that when prostate cancer among male relatives of breast cancer probands (unselected for family history or early‐onset disease) is considered a pleiotrophic effect of the same gene that increases the risk for breast cancer, women are predicted to have a less than 1 in 5 risk of developing breast cancer when they carry the putative high‐risk allele. However, this is a higher risk than in the general Icelandic population. Our results suggest that BRCA2 mutations alone are inadequate to explain all of the excess clustering of prostate cancer cases in families of breast cancer probands, and that additional genes conferring excess risk to both breast and prostate cancer may exist in this population. Genet. Epidemiol. 23:349–363, 2002.Keywords
Funding Information
- National Institutes of Health (Training Grants 5R25CA57708, 5T32CA09314)
- USPHS (CA-06927)
- Commonwealth of Pennsylvania
This publication has 59 references indexed in Scilit:
- The effect of a single BRCA2 mutation on cancer in IcelandJournal of Medical Genetics, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genesBritish Journal of Cancer, 2002
- Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancerHuman Genetics, 2000
- Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relativesInternational Journal of Cancer, 2000
- Evidence for Autosomal Dominant Inheritance of Prostate CancerAmerican Journal of Human Genetics, 1998
- A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypesNature Genetics, 1996
- Epidemiology of breast cancer in families in Iceland.Journal of Medical Genetics, 1992
- Ascertainment in the sequential sampling of pedigreesClinical Genetics, 1977
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974